At Havas, we believe effective teams are small, experienced and, above all, made up of people who are ridiculously passionate about what you want to achieve and have the breadth of skills you need to achieve it.
By pulling in the best talent from across our UK group (from advertising, digital, PR & social, eCRM, design, local activations and media), we will build you a client-centric team that delivers exciting, relevant work “that works”.
A team that can rapidly evolve to cater to any and all of your changing needs and yet remain under its own P&L.
This is how, together, we build a brilliant relationship.
‘MY LIFE. MY RULES. MY MORNING AFTER’
ELLAONE® BIDS TO END STIGMA AROUND EMERGENCY CONTRACEPTION
WITH DEFIANT, EMPOWERING MANIFESTO FOR WOMEN
- Campaign from Havas London and HRA Pharma for the most effective morning after pill-
ellaOne® – the most effective morning after pill – has launched a new marketing campaign aimed at ending the stigma around emergency contraception and tackling the abundance of misconceptions around the morning after pill itself.
‘My Morning After’ – devised by creative agency Havas London – is ellaOne’s® first major campaign since it became available over the counter without a prescription in the UK in 2015. Targeting women aged between 18 and 25, it largely comprises digital and social media activity and centres around a positive, defiant manifesto empowering women who have had unprotected sex or whose contraceptive method has failed:
It’s the morning after the night before I know what they’re thinking, and I feel insecure So an accident happened, this much I know We were together last night, yet I feel so alone
Do I let it get to me? Why should I? Why should we?
Because this body is mine I can still be protected Decisions like this, they should be respected
A baby? Maybe. One day, we’ll see But what I’m doing right now is the right thing for me Because it’s my future. I am my own master
It’s my life. My rules. My Morning After.
These words were brought to life through a 60’ film following the stories of five women from different backgrounds, but with at least one thing in common: they’re all taking control of their morning after. An honest, authentic and relatable portrayal shot by Pulse Films’ Stella Scott, it aims to remove the societal and emotional barriers to entry by normalising the use of ellaOne® when contraception has failed – while simultaneously celebrating women being in control of their own bodies.
It also aims to debunk some of the common myths around the morning after pill, including that it’s difficult to get hold of (it isn’t – it’s available over the counter or online without a prescription), that it can affect future fertility (it doesn't - there is no delay in the return to fertility after taking the morning after pill), that it only works the morning after (morning after pills can be taken up to 3-5 days after unprotected sex) and that it can terminate a pregnancy if you’re already pregnant (ellaOne® is not an abortion pill and so will not interrupt an existing pregnancy – instead, it acts to stop or delay ovulation to prevent conception taking place).
Kate Evans, Marketing Director UK, Ireland & Nordics at HRA Pharma, says: “While category awareness is high, awareness of ellaOne® as a product remains low, despite it being the most effective on the market. Sadly, there also remains a cultural stigma around emergency contraception itself. This campaign aims to break down those barriers and empower women to make the right decision for them, without fear of judgement.”
Aaron Howard, Creative Director at Havas London, adds: “Sometimes accidents happen. There’s no shame in that. ellaOne® is a product that has widened the choices around emergency contraception for women – but this is bigger than merely extolling product benefits. We’re promoting an attitude. And if we go some way to shaping a culture that gives women confidence – and couples for that matter – then we’ve done our job.”
ellaOne® is the world’s most effective morning after pill. It is the only emergency contraceptive product to contain the active ingredient Ulipristal Acetate – which last year was added to the World Health Organization’s Model List of Essential Medicines.